2005 Highlights From: First Annual Lung Cancer Symposium, New York, NY, November 2005 Fulltext Access 6 Pages 2006
Gemcitabine/Carboplatin in a Modified 21-Day Administration Schedule for Advanced-Stage Non-Small-Cell Lung Cancer Fulltext Access 6 Pages 2006
Phase II Trial of Concurrent Paclitaxel, Carboplatin, and External-Beam Radiation Followed by Surgical Resection in Locally Advanced Non–Small-Cell Lung Cancer, Protocol 99-444 Fulltext Access 6 Pages 2006
DNA Methyltransferases Messenger RNA Expression and Aberrant Methylation of CpG Islands in Non-Small-Cell Lung Cancer: Association and Prognostic Value Fulltext Access 6 Pages 2006
Cell-Free DNA Concentration in Pleural Fluid and Serum: Quantitative Approach and Potential Prognostic Factor in Patients with Cancer and Pleural Effusions Fulltext Access 6 Pages 2006
Long-Term Survival with Concurrent Chemoradiation Therapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S9504) Fulltext Access 6 Pages 2006
Evolving Role of Interventional Pulmonology in the Interdisciplinary Approach to the Staging and Management of Lung Cancer: Bronchoscopic Mediastinal Staging of Lung Cancer Fulltext Access 6 Pages 2006
Computed Tomography Screening for Lung Cancer: Applicability of an International Protocol in a Single-Institution Environment Fulltext Access 6 Pages 2006
Asian Ethnicity as a Predictor of Response in Patients with Non–Small-Cell Lung Cancer Treated with Gefitinib on an Expanded Access Program Fulltext Access 6 Pages 2006
Weekly Docetaxel/Estramustine Phosphate in Patients with Increasing Serum Prostate-Specific Antigen Levels After Primary Treatment for Prostate Cancer: A Phase II Trial of the Minnie Pearl Cancer Research Network Fulltext Access 6 Pages 2006
A Phase I Study of Paclitaxel/Doxorubicin/Thalidomide in Patients with Androgen-Independent Prostate Cancer Fulltext Access 6 Pages 2006
Combination Therapy of Imatinib Mesylate and Interferon-α Demonstrates Minimal Activity and Significant Toxicity in Metastatic Renal Cell Carcinoma: Results of a Single-Institution Phase II Trial Fulltext Access 6 Pages 2006
Prognostic Significance of Plasma Scatter Factor/Hepatocyte Growth Factor Levels in Patients with Metastatic Hormone- Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 150005/9480 Fulltext Access 6 Pages 2006
The Role of Bisphosphonates in the Treatment of Prostate Cancer: Recommendations from an Expert Panel Fulltext Access 6 Pages 2006
Highlights from The 2006 American Society of Clinical Oncology Prostate Cancer Symposium; San Francisco, CA; February 24-26, 2006 Fulltext Access 6 Pages 2006
Thalidomide/Estramustine/Paclitaxel in Metastatic Androgen-Independent Prostate Cancer Fulltext Access 6 Pages 2006
Biologic Correlates of Response and Survival in Patients with Cutaneous T-Cell Lymphoma Treated with Denileukin Diftitox Fulltext Access 6 Pages 2006
Cytomegalovirus Infection in Patients with Lymphoma: An Important Cause of Morbidity and Mortality Fulltext Access 6 Pages 2006
Administration of Latent Membrane Protein 2-Specific Cytotoxic T Lymphocytes to Patients with Relapsed Epstein-Barr Virus-Positive Lymphoma Fulltext Access 6 Pages 2006
Highlights From: 47th Annual Meeting of the American Society of Hematology, December 2005, Atlanta, GA Fulltext Access 6 Pages 2006
CD52 Is Expressed on Human Mast Cells and Is a Potential Therapeutic Target in Waldenström's Macroglobulinemia and Mast Cell Disorders Fulltext Access 6 Pages 2006
Superior 12-Year Survival After at Least 4-Year Continuous Remission with Tandem Transplantations for Multiple Myeloma Fulltext Access 6 Pages 2006
Idiopathic Cholestasis as a Paraneoplastic Phenomenon in Hodgkin's Lymphoma Fulltext Access 6 Pages 2006
Phase I/II Trial of Nonpegylated Liposomal Doxorubicin, Cyclophosphamide, Vincristine, and Prednisone in the Treatment of Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Fulltext Access 6 Pages 2006
Updated Guidelines on the Management of Cytomegalovirus Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Alemtuzumab Fulltext Access 6 Pages 2006
Response to Bortezomib and Activation of Osteoblasts in Multiple Myeloma Fulltext Access 6 Pages 2006
Gefitinib Monotherapy in Chemotherapy-Naive Patients with Inoperable Stage III/IV Non-Small-Cell Lung Cancer Fulltext Access 6 Pages 2006
Prognostic Role of Protease-Activated Receptors 1 and 4 in Resected Stage IB Non-Small-Cell Lung Cancer Fulltext Access 6 Pages 2006
Smoking History and Epidermal Growth Factor Receptor Expression as Predictors of Survival Benefit from Erlotinib for Patients with Non–Small-Cell Lung Cancer in the National Cancer Institute of Canada Clinical Trials Group Study BR.21 Fulltext Access 6 Pages 2006
Pulmonary Dysfunction as a Major Cause of Inoperability Among Patients with Non–Small-Cell Lung Cancer Fulltext Access 6 Pages 2006
Multicenter Randomized Trial for Stage IIIB/IV Non–Small-Cell Lung Cancer Using Every-3-Week Versus Weekly Paclitaxel/Carboplatin Fulltext Access 6 Pages 2006
Sex Differences in the Predictive Power of the Molecular Prognostic Factor HER2/neu in Patients with Non–Small-Cell Lung Cancer Fulltext Access 6 Pages 2006
Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer Fulltext Access 6 Pages 2006
Assessing Drug Risks and Benefits: Lessons from Postmenopausal Hormone Therapy Studies Fulltext Access 6 Pages 2006
Emerging Data on Optimal Adjuvant Endocrine Therapy: Breast International Group Trial 1-98/MA.17 Fulltext Access 6 Pages 2006
2005 Highlights From: The 28th Annual San Antonio Breast Cancer Symposium; San Antonio, TX; December 2005 Fulltext Access 6 Pages 2006
2006 Highlights from: the 42nd Annual Meeting of the American Society of Clinical Oncology; Atlanta, GA, June 2006 Fulltext Access 6 Pages 2006
NSABP B-42: A Clinical Trial to Determine the Efficacy of Five Years of Letrozole Compared with Placebo in Patients Completing Five Years of Hormonal Therapy Consisting of an Aromatase Inhibitor (AI) or Tamoxifen Followed by an AI in Prolonging Disease-Fr Fulltext Access 6 Pages 2006
Pemetrexed in Patients with Locally Advanced or Metastatic Breast Cancer Who Had Received Previous Anthracycline and Taxane Treatment: Phase II Study Fulltext Access 6 Pages 2006
Risk of Cancer Treatment—Associated Bone Loss and Fractures Among Women with Breast Cancer Receiving Aromatase Inhibitors Fulltext Access 6 Pages 2006
Interleukin-2 Therapy of Metastatic Renal Cell Carcinoma: Update of Phase III Trials Fulltext Access 6 Pages 2006
Have Palliative Care Teams' Attitudes Toward Venous Thromboembolism Changed? A Survey of Thromboprophylaxis Practice Across British Specialist Palliative Care Units in the Years 2000 and 2005 Fulltext Access 6 Pages 2006
Nociceptin Levels in the Cerebrospinal Fluid of Chronic Pain Patients With or Without Intrathecal Administration of Morphine Fulltext Access 6 Pages 2006
Opioid Switching from Morphine to Methadone Causes a Minor But Not Clinically Significant Increase in QTc Time: A Prospective 9-Month Follow-Up Study Fulltext Access 6 Pages 2006
Spinal Cord Stimulation for Critical Leg Ischemia: A Review of Effectiveness and Optimal Patient Selection Fulltext Access 6 Pages 2006
Impact of Prognostic Factors on Clinical Outcome After Resection of Colorectal Pulmonary Metastases Fulltext Access 6 Pages 2006
Highlights from: The Third International Congress on Kidney and Bladder Cancer; Orlando, FL; August 3-6, 2006 Fulltext Access 6 Pages 2006
Development of an Integrated Prostate Cancer Research Information System Fulltext Access 6 Pages 2006
Expression and Clinical Significance of Methylenetetrahydrofolate Reductase in Patients with Colorectal Cancer Fulltext Access 6 Pages 2006
Colorectal Cancer Screening Using Stool DNA Analysis in Clinical Practice: Early Clinical Experience with Respect to Patient Acceptance and Colonoscopic Follow-up of Abnormal Tests Fulltext Access 6 Pages 2006
Combining Imatinib with Surgery in Gastrointestinal Stromal Tumors: Rationale and Ongoing Trials Fulltext Access 6 Pages 2006
Addition of Gabapentin to a Modified FOLFOX Regimen Does Not Reduce Oxaliplatin-Induced Neurotoxicity Fulltext Access 6 Pages 2006
Phase III Multicenter Randomized Clinical Trial to Evaluate the Safety and Efficacy of CoFactor®/5-Fluorouracil/Bevacizumab Versus Leucovorin/5-Fluorouracil/Bevacizumab as Initial Treatment for Metastatic Colorectal Carcinoma Fulltext Access 6 Pages 2006
Do All Patients with Metastatic Colorectal Cancer Need Chemotherapy Until Disease Progression? Fulltext Access 6 Pages 2006
Phase I Study of Gefitinib plus FOLFIRI in Previously Untreated Patients with Metastatic Colorectal Cancer Fulltext Access 6 Pages 2006
Liver Resection for Metastatic Colorectal Cancer in the Age of Neoadjuvant Chemotherapy and Bevacizumab Fulltext Access 6 Pages 2006
Diverticular Disease in Patients with Colon Cancer: Subgroup Analysis of National Surgical Adjuvant Breast and Bowel Project Protocol C-06 Fulltext Access 6 Pages 2006
Rétention des allergènes d'acariens par un tissu utilisé pour la fabrication de housses de matelas intégrales Fulltext Access 7 Pages 2006
Évaluation de l'influence des recommandations OMS–ARIA sur la prise en charge de la rhinite allergique en pratique de ville en France. Enquête ERNANI Fulltext Access 7 Pages 2006
Audit environnemental des logements : intérêt d'identifier la ou les moisissure(s) en cause Fulltext Access 7 Pages 2006
La comparaison des taux de sensibilisation IgE-dépendante aux moisissures, aux dermatophytes et aux levures dans les maladies allergiques générales et les dermatoses inflammatoires Fulltext Access 7 Pages 2006
Congrès francophone pédiatrique de pneumologie et d'allergologie. Atelier de l'Anaforcal Fulltext Access 7 Pages 2006
Dynamique des complexes de signalisation qui contrôlent l'activation des mastocytes Fulltext Access 7 Pages 2006
Mise au point d'un dosage automatisé des IgE spécifiques des allergènes des pollens de cyprès et de genévrier par VIDAS Stallergy Fulltext Access 7 Pages 2006
Les plantes transgéniques (OGM végétaux) : connaissances et inconnues sur les risques d'allergénicité… Fulltext Access 7 Pages 2006
Les récepteurs pour la portion Fc des anticorps, cibles et/ou outils thérapeutiques dans l'allergie Fulltext Access 7 Pages 2006
Diagnostic biologique de l'allergie respiratoire : évaluation du réactif Vidas Stallergy genévrier dans l'allergie au cyprès Fulltext Access 7 Pages 2006
Highlights From: 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, December 10-13, 2005 Fulltext Access 7 Pages 2006
Highights From: 47th Annual Meeting of the American Society of Hematology, December 2005, Atlanta, GA Fulltext Access 7 Pages 2006
High Clinical Response Rate with Multimodality Immunomodulatory Therapy for Sézary Syndrome Fulltext Access 7 Pages 2006
Phase I Trial of First-Line Bortezomib/Thalidomide plus Chemotherapy for Induction and Stem Cell Mobilization in Patients with Multiple Myeloma Fulltext Access 7 Pages 2006
Arsenic Compounds in the Treatment of Multiple Myeloma: A New Role for a Historical Remedy Fulltext Access 7 Pages 2006
Use of Single Nucleotide Polymorphism–Based Mapping Arrays to Detect Copy Number Changes and Loss of Heterozygosity in Multiple Myeloma Fulltext Access 7 Pages 2006
Interactions Between Hypoxia and Epidermal Growth Factor Receptor in Non–Small-Cell Lung Cancer Fulltext Access 7 Pages 2006
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer: Impact of Primary or Secondary Mutations Fulltext Access 7 Pages 2006
Current Approaches to Advanced-Stage Non–Small-Cell Lung Cancer: First-Line Therapy in Patients with a Good Functional Status Fulltext Access 7 Pages 2006
A Retrospective Analysis of Second-Line Chemotherapy or Best Supportive Care in Patients with Advanced-Stage Non–Small-Cell Lung Cancer Fulltext Access 7 Pages 2006